Qing Liu, BS; Shannon Waltz, BS; Grace Woodruff, BS; et al.
free access
JAMA Neurol. 2014;71(12):1481-1489. doi:10.1001/jamaneurol.2014.2482
This study using cellular models reports that human neurons derived from human induced pluripotent stem cells provide a signature that will accurately reflect drug response in humans and in cerebrospinal fluid biomarker changes during γ-secretase modulator treatment for Alzheimer disease. Liao and Holtzman provide a related .
Raquel C. Gardner, MD; James F. Burke, MD, MS; Jasmine Nettiksimmons, PhD; et al.
free access
JAMA Neurol. 2014;71(12):1490-1497. doi:10.1001/jamaneurol.2014.2668
This retrospective cohort study found that patients with traumatic brain injury had an increased risk of developing dementia. See also the Editorial by DeKosky.
Claudio Liguori, MD; Andrea Romigi, MD, PhD; Marzia Nuccetelli, PhD; et al.
free access
JAMA Neurol. 2014;71(12):1498-1505. doi:10.1001/jamaneurol.2014.2510
This case-control study demonstrates that, in Alzheimer disease, increased cerebrospinal fluid orexin levels are related to a parallel sleep deterioration, which appears to be associated with the cognitive decline.
Annette Langer-Gould, MD, PhD; Lei Qian, PhD; Sara Y. Tartof, PhD; et al.
free access
JAMA Neurol. 2014;71(12):1506-1513. doi:10.1001/jamaneurol.2014.2633
This nested, case-control study reports no longer-term association of vaccines with multiple sclerosis or other acquired central nervous system demyelinating diseases; however, there was a short-term increase in risk.
Sandra Barral, PhD; Stephanie Cosentino, PhD; Kaare Christensen, MD, PhD, DMSc; et al.
free access
JAMA Neurol. 2014;71(12):1514-1519. doi:10.1001/jamaneurol.2014.1663
This genome-wide linkage analysis provides evidence for the presence of potential candidate genes related to exceptional episodic memory in the elderly.
David S. Russell, MD, PhD; Olivier Barret, PhD; Danna L. Jennings, MD; et al.
free access
JAMA Neurol. 2014;71(12):1520-1528. doi:10.1001/jamaneurol.2014.1954
This prospective cohort study identifies [18F]MNI-659 as a promising striatal imaging biomarker for assessment of early Huntington disease.
Annalese G. Neuenschwander; Khanh K. Thai, MS; Karla P. Figueroa, MS; et al.
free access
JAMA Neurol. 2014;71(12):1529-1534. doi:10.1001/jamaneurol.2014.2082
This meta-analysis assesses the association between the number of CAG repeat alleles in the ataxin 2 gene (ATXN2) and the risk of amyotrophic lateral sclerosis across multiple ethnic groups.
Joanne Trinh, BSc; Ilaria Guella, PhD; Matthew James Farrer, PhD
free access
JAMA Neurol. 2014;71(12):1535-1539. doi:10.1001/jamaneurol.2014.1909
This quantitative meta-analysis reveals that Parkinson disease pathogenic mutations have an age-dependent penetrance that could be ameliorated or exacerbated by modifier genes or environmental factors in different populations.
Rebekah M. Ahmed, MBBS; Muireann Irish, PhD; Jonathan Kam, MD; et al.
free access
JAMA Neurol. 2014;71(12):1540-1546. doi:10.1001/jamaneurol.2014.1931
This prospective case-controlled study shows that abnormal eating behaviors are prominent in patients with behavioral variant frontotemporal dementia and those with semantic dementia.
Kejal Kantarci, MD, MS; Christopher G. Schwarz, PhD; Robert I. Reid, PhD; et al.
free access
JAMA Neurol. 2014;71(12):1547-1554. doi:10.1001/jamaneurol.2014.1482
This population-based, longitudinal cohort study shows that a high amyloid load does not influence diffusion tensor imaging–based measures of white matter integrity in the absence of coexistent gray matter neurodegeneration in older adults without dementia.